evoke pharma stock target

The average Evoke Pharma stock forecast 2030 represents a 84595 increase from the last price of 322000002861023. Discover the Power of thinkorswim Today.

Evok Stock Price And Chart Nasdaq Evok Tradingview

Evoke Pharma Incs variance in analysts estimates is less than.

. Evoke Pharma Incs average analyst price target is higher than 1754 of all US stocks. Trades from 1. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal GI disorders and diseases.

The more significant the discrepancy between the. Evoke Pharma Inc. 15 2017 at 839 am.

Today California-based Evoke Pharma NASDAQ. So far the community has only identified positive things for Evoke Pharma Inc. The number of analysts covering the stock of EVOK is higher than 1307 of Healthcare stocks.

The average Evoke Pharma stock price prediction forecasts a potential upside of 20864 from the current EVOK share price of 324. - USA Stock USD 026 282 9156 Evoke Pharma stock price prediction is an act of determining the future value of Evoke Pharma shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuation. ET by Tomi Kilgore Evoke Pharma shares plunge 75 to pace Nasdaq losers after drug trial.

The price targets of various analysts who make up the consensus differ significantly. It has underperformed other stocks in the Drug Manufacturers - Specialty Generic industry by 043 percentage points. Ad The 7 Stocks youll want to own for their consistent and reliable increases in yields.

EVOK IEX Real-Time Price USD. The most positive votes were given for criterium Worthwhile Investment for the next years. That Evoke Pharmas share price could reach 1000 by Nov 16 2021.

Analyst ratings historical stock prices earnings estimates actuals. Evoke Pharma Stock Forecast BUY NASDAQEVOK. Stock Price Forecast According to 8 stock analysts the average 12-month stock price forecast for EVOK stock is 7956 which predicts an increase of 250852.

Evoke Pharma EVOK Quote Overview More Research Evoke Pharma EVOK Price Target Stock Forecast. About Evoke Pharma Inc. Ad This analysts last stock recommendations soared hundreds of percent very quickly.

With a target price of 12000 there is potential for a 3900000 increase which would mean more than doubling the current price of 300 for Evoke Pharma Inc. The average price target for EVOK is 10 and analysts rate the stock as a Strong Buy. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases.

HC Wainwright Co. The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months. The lowest target is 3636 and the highest is 126.

Based On Fundamental Analysis. Evoke Pharmas stock soars 19 premarket after positive FDA product assessment Feb. Evoke Pharma Inc.

EVOK stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Price Target Change Rating Change Previous Current Rating. By Shrey Dua InvestorPlace Assistant News Writer Apr 26 2022 217 pm EDT.

EVOK is up a jaw-dropping 130 so far on surprising regulatory news. InvestorsObserver is giving Evoke Pharma Inc EVOK an Analyst Rating Rank of 78 meaning EVOK is ranked higher by analysts than 78 of stocks. Evoke Pharma stock last closed at 305 up 099 from the previous day and has decreased 777 in one year.

On the other hand Evoke Pharmas target price is what analysts think the stock is worth or could sell for in the future. Ad Our Strong Buys Double the SP. See Evoke Pharma Inc.

The company developed commercialized and markets GIMOTI a nasal spray formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults. Evoke Pharma reported quarterly losses of 7 cents. Evoke is a specialty pharmaceutical company that owns and operates in the development and commercialization of pharmaceutical products.

Evoke Pharma Inc NASDAQ. Whats Up With Evoke Pharmas Stock Popping Off Friday. Find out which stock could jump next.

For Evoke Pharma stock forecast for 2032 10 year 7 predictions are offered for each month of 2032 with average Evoke Pharma stock forecast of 166 a high forecast of 1824 and a low forecast of 155. 305 003 099. The Wall Street analyst predicted.

Find the latest Evoke Pharma Inc. EVOK analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Dow Jones a News Corp company About WSJ.

The current price of Evoke Pharma is the price at which Evoke Pharma is currently trading. Evoke is developing its product Gimoti. EVOK shares are trading higher by 231 at 138 after the company reported better-than-expected second-quarter EPS results.

Stock Price Forecast The 1 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 3600 with a high estimate of 3600 and a low estimate of 3600. New report out now. Free report details the dividend stocks to buy and hold in retirement.

Evoke Pharma Inc a specialty pharmaceutical company primarily focuses on the development of drugs for the. Evoke Pharmas current and average target prices are 305 and 1000 respectively. This reflects different assessments andor a difficulty in valuing the company.

5000 Hadley Center Dr South Plainfield NJ 07080-1135 908-444-2023. EVOK updated stock price target summary. Evoke Pharma stock is currently 5025 from its 52-week low of 203 and -8391 from its 52-week high of 1896.

Evok Stock Price And Chart Nasdaq Evok Tradingview